Source link : https://www.newshealth.biz/health-news/two-investigational-treatments-for-als-show-glimmer-of-hope/
(MedPage Today) — The first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase II studies, but two treatments — pridopidine and CNM-Au8 — showed glimmers of hope. All treatments… Source link : https://www.medpagetoday.com/neurology/generalneurology/114246 Author : Publish date : 2025-02-17 16:01:00 Copyright for syndicated content belongs […]
Author : News Health
Publish date : 2025-02-17 16:01:00
Copyright for syndicated content belongs to the linked Source.